Calypxo Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Calypxo Pain Relief
Generic name: METHYL SALICYLATE, MENTHOL
Manufacturer: Asclemed USA, Inc
Product type: HUMAN OTC DRUG
SPL set ID: bd9d0bc0-5705-4c73-bcd6-f6cdb68e05b6
SPL ID: 07cec8ef-ecc9-ac49-e063-6294a90a6083
Version: 6
Effective date: 2023-10-16
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:40:26

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Calypxo Pain Relief	openfda.brand_name
generic name		METHYL SALICYLATE, MENTHOL	openfda.generic_name
manufacturer name		Asclemed USA, Inc	openfda.manufacturer_name
ndc	package	76420-450-12	openfda.package_ndc
ndc	product	76420-450	openfda.product_ndc
ndc11	package	76420045012	derived:openfda.package_ndc
rxcui		1486874	openfda.rxcui
spl id		07cec8ef-ecc9-ac49-e063-6294a90a6083	id
spl set id		bd9d0bc0-5705-4c73-bcd6-f6cdb68e05b6	set_id
unii		L7T10EIP3A	openfda.unii
unii		LAV5U5022Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning For external use only. Avoid contact with eyes and mucous membranes. Do not bandage tightly or cover treated areas. Do not use with heating pad. Do not apply to open wounds or damages skin. A mild burning sensation may occur. If severe burning sensation occurs, discontinue use immediately. If symptoms persist for more than seven days, discontinue use and consult physician. Keep out of reach of children. If swallowed, consult physician. If pregnant or breast feeding, contact physician prior to use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.